{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:36:46Z","timestamp":1789522606307,"version":"build-2803163510"},"reference-count":42,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To identify potential oncogenes that contribute to the development of uterine leiomyosarcoma, we conducted a cDNA microarray analysis between normal uterine smooth muscle and uterine leiomyosarcoma. We found that acrogranin (also named PCDGF or progranulin) is overexpressed in uterine leiomyosarcoma. With immunohistochemical staining of 12 leiomyosarcoma cases, we verified acrogranin expression in tumor cells. Furthermore, the intensity of acrogranin expression correlated with high histologic grade and poor prognosis. To directly analyze the oncogenic properties of acrogranin, we established an immortalized uterine smooth muscle cell line by transfection of human telomerase reverse transcriptase into primary culture. This cell line retained the original characteristics of uterine smooth muscle cells, including spindle-shaped extension as well as expression of vimentin, estrogen receptor \u03b1, progesterone receptor, and \u03b1 smooth muscle actin. Transfection of acrogranin into the immortalized uterine smooth muscle cells resulted in colony formation in soft agar, but the diameter of the colonies did not exceed 100 \u03bcm. Transfection of both acrogranin and SV40 early region (SV40ER) into the immortalized uterine smooth muscle cells resulted in an increased number of colonies and increased colony size in soft agar versus transfection of SV40ER alone. We show that only immortalized uterine smooth muscle cells expressing both acrogranin and SV40ER are capable of tumor formation in nude mice. Thus, acrogranin is overexpressed in uterine leiomyosarcoma cells, particularly in high-grade cases, and forced expression of acrogranin in immortalized uterine smooth muscle cells contributes to malignant transformation, which suggest that acrogranin plays an important role in the pathogenesis of uterine leiomyosarcoma.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-05-2003","type":"journal-article","created":{"date-parts":[[2006,3,21]],"date-time":"2006-03-21T18:43:43Z","timestamp":1142966623000},"page":"1402-1411","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Oncogenic Property of Acrogranin in Human Uterine Leiomyosarcoma: Direct Evidence of Genetic Contribution in <i>In vivo<\/i> Tumorigenesis"],"prefix":"10.1158","volume":"12","author":[{"given":"Noriomi","family":"Matsumura","sequence":"first","affiliation":[{"name":"Authors' Affiliation: Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mandai","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Miyanishi","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Baba","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Kariya","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takakura","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Fujii","sequence":"additional","affiliation":[{"name":"Authors' Affiliation: Department of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,3,6]]},"reference":[{"key":"2022061106360269900_B1","doi-asserted-by":"crossref","unstructured":"Echt G, Jepson J, Steel J, et al. Treatment of uterine sarcomas. Cancer\u20081990;66:35\u20139.","DOI":"10.1002\/1097-0142(19900701)66:1<35::AID-CNCR2820660108>3.0.CO;2-V"},{"key":"2022061106360269900_B2","doi-asserted-by":"crossref","unstructured":"Gadducci A, Landoni F, Sartori E, Zola P, Maggino T, Lissoni A. Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol\u20081996;62:25\u201332.","DOI":"10.1006\/gyno.1996.0185"},{"key":"2022061106360269900_B3","doi-asserted-by":"crossref","unstructured":"Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein M, Dunne ME. Uterine sarcomas: natural history, treatment and prognosis. Cancer\u20081978;42:1152\u201360.","DOI":"10.1002\/1097-0142(197809)42:3<1152::AID-CNCR2820420319>3.0.CO;2-L"},{"key":"2022061106360269900_B4","doi-asserted-by":"crossref","unstructured":"Dusenbery KE, Potish RA, Judson P. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus. Gynecol Oncol\u20082004;94:191\u20136.","DOI":"10.1016\/j.ygyno.2004.04.001"},{"key":"2022061106360269900_B5","doi-asserted-by":"crossref","unstructured":"Giuntoli RL II, Bristow RE. Uterine leiomyosarcoma: present management. Curr Opin Oncol\u20082004;16:324\u20137.","DOI":"10.1097\/01.cco.0000127721.55676.f6"},{"key":"2022061106360269900_B6","doi-asserted-by":"crossref","unstructured":"Perez EA, Pusztai L, Van de Vijver M. Improving patient care through molecular diagnostics. Semin Oncol\u20082004;31:14\u201320.","DOI":"10.1053\/j.seminoncol.2004.07.017"},{"key":"2022061106360269900_B7","doi-asserted-by":"crossref","unstructured":"Zhou J, Gao G, Crabb JW, Serrero G. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. J Biol Chem\u20081993;268:10863\u20139.","DOI":"10.1016\/S0021-9258(18)82064-6"},{"key":"2022061106360269900_B8","doi-asserted-by":"crossref","unstructured":"Bhandari V, Palfree RG, Bateman A. Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains. Proc Natl Acad Sci U S A\u20081992;89:1715\u20139.","DOI":"10.1073\/pnas.89.5.1715"},{"key":"2022061106360269900_B9","doi-asserted-by":"crossref","unstructured":"Daniel R, Daniels E, He Z, Bateman A. Progranulin (acrogranin\/PC cell-derived growth factor\/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Dev Dyn\u20082003;227:593\u20139.","DOI":"10.1002\/dvdy.10341"},{"key":"2022061106360269900_B10","doi-asserted-by":"crossref","unstructured":"He Z, Ong CH, Halper J, Bateman A. Progranulin is a mediator of the wound response. Nat Med\u20082003;9:225\u20139. Epub 2003 Jan 13.","DOI":"10.1038\/nm816"},{"key":"2022061106360269900_B11","doi-asserted-by":"crossref","unstructured":"Cheung ST, Wong SY, Leung KL, et al. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res\u20082004;10:7629\u201336.","DOI":"10.1158\/1078-0432.CCR-04-0960"},{"key":"2022061106360269900_B12","doi-asserted-by":"crossref","unstructured":"Davidson B, Alejandro E, Florenes VA, et al. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. Cancer\u20082004;100:2139\u201347.","DOI":"10.1002\/cncr.20219"},{"key":"2022061106360269900_B13","doi-asserted-by":"crossref","unstructured":"Pan CX, Kinch MS, Kiener PA, et al. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Clin Cancer Res\u20082004;10:1333\u20137.","DOI":"10.1158\/1078-0432.CCR-1123-03"},{"key":"2022061106360269900_B14","doi-asserted-by":"crossref","unstructured":"Serrero G, Ioffe OB. Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium. Hum Pathol\u20082003;34:1148\u201354.","DOI":"10.1016\/S0046-8177(03)00425-8"},{"key":"2022061106360269900_B15","unstructured":"Jones MB, Michener CM, Blanchette JO, et al. The granulin-epithelin precursor\/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Clin Cancer Res\u20082003;9:44\u201351."},{"key":"2022061106360269900_B16","unstructured":"Liau LM, Lallone RL, Seitz RS, et al. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Res\u20082000;60:1353\u201360."},{"key":"2022061106360269900_B17","unstructured":"He Z, Bateman A. Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res\u20081999;59:3222\u20139."},{"key":"2022061106360269900_B18","doi-asserted-by":"crossref","unstructured":"Lu R, Serrero G. Inhibition of PC cell-derived growth factor (PCDGF, epithelin\/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proc Natl Acad Sci U S A\u20082000;97:3993\u20138.","DOI":"10.1073\/pnas.97.8.3993"},{"key":"2022061106360269900_B19","doi-asserted-by":"crossref","unstructured":"Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature\u20081999;400:464\u20138.","DOI":"10.1038\/22780"},{"key":"2022061106360269900_B20","doi-asserted-by":"crossref","unstructured":"Kusakari T, Kariya M, Mandai M, et al. C-erbB-2 or mutant Ha-ras induced malignant transformation of immortalized human ovarian surface epithelial cells in vitro. Br J Cancer\u20082003;89:2293\u20138.","DOI":"10.1038\/sj.bjc.6601423"},{"key":"2022061106360269900_B21","doi-asserted-by":"crossref","unstructured":"Liu J, Yang G, Thompson-Lanza JA, et al. A genetically defined model for human ovarian cancer. Cancer Res\u20082004;64:1655\u201363.","DOI":"10.1158\/0008-5472.CAN-03-3380"},{"key":"2022061106360269900_B22","doi-asserted-by":"crossref","unstructured":"Zhao JJ, Gjoerup OV, Subramanian RR, et al. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell\u20082003;3:483\u201395.","DOI":"10.1016\/S1535-6108(03)00088-6"},{"key":"2022061106360269900_B23","doi-asserted-by":"crossref","unstructured":"Lundberg AS, Randell SH, Stewart SA, et al. Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene\u20082002;21:4577\u201386.","DOI":"10.1038\/sj.onc.1205550"},{"key":"2022061106360269900_B24","doi-asserted-by":"crossref","unstructured":"MacKenzie KL, Franco S, Naiyer AJ, et al. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. Oncogene\u20082002;21:4200\u201311.","DOI":"10.1038\/sj.onc.1205425"},{"key":"2022061106360269900_B25","unstructured":"Rich JN, Guo C, McLendon RE, Bigner DD, Wang XF, Counter CM. A genetically tractable model of human glioma formation. Cancer Res\u20082001;61:3556\u201360."},{"key":"2022061106360269900_B26","doi-asserted-by":"crossref","unstructured":"Kanamori T, Takakura K, Mandai M, et al. PEP-19 overexpression in human uterine leiomyoma. Mol Hum Reprod\u20082003;9:709\u201317.","DOI":"10.1093\/molehr\/gag088"},{"key":"2022061106360269900_B27","unstructured":"Blaustein's pathology of the female genital tract. 5th ed. New York: Springer-Verlag, Inc.; 2002. p. 561\u2013615."},{"key":"2022061106360269900_B28","doi-asserted-by":"crossref","unstructured":"Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol\u20081994;18:535\u201358.","DOI":"10.1097\/00000478-199406000-00001"},{"key":"2022061106360269900_B29","doi-asserted-by":"crossref","unstructured":"Condon J, Yin S, Mayhew B, et al. Telomerase immortalization of human myometrial cells. Biol Reprod\u20082002;67:506\u201314.","DOI":"10.1095\/biolreprod67.2.506"},{"key":"2022061106360269900_B30","doi-asserted-by":"crossref","unstructured":"Carney SA, Tahara H, Swartz CD, et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest\u20082002;82:719\u201328.","DOI":"10.1097\/01.LAB.0000017499.51216.3E"},{"key":"2022061106360269900_B31","doi-asserted-by":"crossref","unstructured":"Soloff MS, Jeng YJ, Ilies M, et al. Immortalization and characterization of human myometrial cells from term-pregnant patients using a telomerase expression vector. Mol Hum Reprod\u20082004;10:685\u201395. Epub 2004 Jul 8.","DOI":"10.1093\/molehr\/gah086"},{"key":"2022061106360269900_B32","doi-asserted-by":"crossref","unstructured":"He Z, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med\u20082003;81:600\u201312.","DOI":"10.1007\/s00109-003-0474-3"},{"key":"2022061106360269900_B33","doi-asserted-by":"crossref","unstructured":"Serrero G. Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochem Biophys Res Commun\u20082003;308:409\u201313.","DOI":"10.1016\/S0006-291X(03)01452-9"},{"key":"2022061106360269900_B34","doi-asserted-by":"crossref","unstructured":"Hrabal R, Chen Z, James S, Bennett HP, Ni F. The hairpin stack fold, a novel protein architecture for a new family of protein growth factors. Nat Struct Biol\u20081996;3:747\u201352.","DOI":"10.1038\/nsb0996-747"},{"key":"2022061106360269900_B35","doi-asserted-by":"crossref","unstructured":"Daniel R, He Z, Carmichael KP, Halper J, Bateman A. Cellular localization of gene expression for progranulin. J Histochem Cytochem\u20082000;48:999\u20131009.","DOI":"10.1177\/002215540004800713"},{"key":"2022061106360269900_B36","doi-asserted-by":"crossref","unstructured":"Rangarajan A, Hong SJ, Gifford A, Weinberg RA. Species- and cell type-specific requirements for cellular transformation. Cancer Cell\u20082004;6:171\u201383.","DOI":"10.1016\/j.ccr.2004.07.009"},{"key":"2022061106360269900_B37","doi-asserted-by":"crossref","unstructured":"Akagi T. Oncogenic transformation of human cells: shortcomings of rodent model systems. Trends Mol Med\u20082004;10:542\u20138.","DOI":"10.1016\/j.molmed.2004.09.001"},{"key":"2022061106360269900_B38","doi-asserted-by":"crossref","unstructured":"Bocchetta M, Carbone M. Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation. Oncogene\u20082004;23:6484\u201391.","DOI":"10.1038\/sj.onc.1207855"},{"key":"2022061106360269900_B39","doi-asserted-by":"crossref","unstructured":"Zhao JJ, Roberts TM, Hahn WC. Functional genetics and experimental models of human cancer. Trends Mol Med\u20082004;10:344\u201350.","DOI":"10.1016\/j.molmed.2004.05.005"},{"key":"2022061106360269900_B40","doi-asserted-by":"crossref","unstructured":"Campbell PM, Der CJ. Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol\u20082004;14:105\u201314.","DOI":"10.1016\/j.semcancer.2003.09.015"},{"key":"2022061106360269900_B41","doi-asserted-by":"crossref","unstructured":"Xu SQ, Tang D, Chamberlain S, et al. The granulin\/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. J Biol Chem\u20081998;273:20078\u201383.","DOI":"10.1074\/jbc.273.32.20078"},{"key":"2022061106360269900_B42","unstructured":"Zanocco-Marani T, Bateman A, Romano G, Valentinis B, He ZH, Baserga R. Biological activities and signaling pathways of the granulin\/epithelin precursor. Cancer Res\u20081999;59:5331\u201340."}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/12\/5\/1402\/1923043\/1402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/12\/5\/1402\/1923043\/1402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T21:34:49Z","timestamp":1654983289000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/12\/5\/1402\/203577\/Oncogenic-Property-of-Acrogranin-in-Human-Uterine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,3,6]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-05-2003","relation":{},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}